Skip to main navigation Skip to search Skip to main content

Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer

  • Sera Lim
  • , Yesol Kim
  • , Soo Been Lee
  • , Hyeok Gu Kang
  • , Da Hyun Kim
  • , Jee Won Park
  • , Daeun Chung
  • , Hyunkyung Kong
  • , Kyung Hyun Yoo
  • , Yonghwan Kim
  • , Wonshik Han
  • , Kyung Hee Chun
  • , Jong Hoon Park

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology